Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. provides technology, engineering and mission-focused solutions for defense, intelligence, civil, health, commercial and international customers. News about LDOS commonly covers operating results, guidance, dividends, government contract awards, defense systems, digital modernization, health services, air traffic management, autonomous systems and work for U.S. federal agencies.
Company updates also include developments across the National Security & Digital, Health & Civil, Commercial & International and Defense Systems segments, as well as completed acquisitions, material partnerships and production programs such as air and missile defense launchers and secure mission systems.
Leidos (NYSE:LDOS) has secured a follow-on prime contract with the Transportation Security Administration (TSA) valued at approximately $55 million. This contract extends their role in hazardous materials management and disposal across over 430 airports in the U.S., including Alaska and Hawaii. It includes a nine-month base period and four optional one-year periods. Leidos will ensure compliance with regulations involving hazardous waste, including training, audits, and emergency response.
Leidos (NYSE: LDOS) has been awarded a prime task order worth up to $1.5 billion by the Department of Defense. The contract includes a one-year base period and four additional one-year options, focusing on enhancing C5ISR capabilities globally. According to Gerry Fasano, President of Leidos Defense Group, the project aims to integrate advanced technology for improving operational effectiveness in the military. This contract expands Leidos' support for warfighters, providing essential technological innovation in a rapidly evolving defense landscape.
The Leidos Partnership for Defense Health (LPDH) announced the successful deployment of MHS GENESIS electronic health records to 18 military commands, benefiting an additional 10,000 clinicians. This deployment integrates new revenue cycle capabilities, enhancing patient accounting and medical coding. MHS GENESIS now operates at over 1,800 locations, serving 5.1 million Department of Defense beneficiaries, with plans for eight more deployments by the end of 2023. The initiative aims to replace paper-based practices and improve communication within the military health system.
Leidos (NYSE: LDOS), a leading science and technology company, has announced a conference call on November 1, 2022, at 8 a.m. (ET) to discuss its third quarter 2022 financial results for the period ending September 30, 2022. The earnings press release will be issued prior to the call. Investors can access a live broadcast and replay via the company's Investor Relations website. Leidos reported approximately $13.7 billion in annual revenue for 2021, emphasizing its position in the defense and intelligence sectors.
Leidos (NYSE: LDOS) announced the appointment of retired Vice Admiral David Lewis as Senior Vice President, Maritime, effective September 22, 2022. Lewis will enhance the company’s maritime capabilities and drive organic growth across its divisions, which include support for Navy ship design, engineering, and advanced vehicle technology. He brings extensive military and technology experience from the Navy and is expected to provide significant operational advantages for Leidos' maritime initiatives. Leidos reported annual revenues of approximately $13.7 billion for fiscal year 2021.
Leidos (NYSE: LDOS) has secured a Blanket Purchase Agreement (BPA) from the U.S. Department of Transportation (USDOT) to provide program and technical support to the Federal Highway Administration (FHWA). The BPA, valued at $60 million, spans five years with a six-month option. Leidos aims to enhance highway policy, analyze transportation investments, and improve safety measures. This contract expands Leidos' collaboration with USDOT and FHWA, reinforcing its position in critical infrastructure and safety services.
Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, has been selected by the U.S. Department of the Air Force to join the Advanced Battle Management System (ABMS) Digital Infrastructure Consortium. This consortium aims to design and deploy Joint All-Domain Command & Control (JADC2) capabilities for the Air Force and Space Force. Leidos will leverage its systems integration and digital modernization expertise to aid the DoD's JADC2 strategy, promoting speed, security, and integration across distributed battle management.
Leidos (NYSE: LDOS) is set to participate in the Morgan Stanley 10th Annual Laguna Conference on September 15, 2022, from 2:35 p.m. to 3:05 p.m. PT in Laguna Niguel, CA.
The company's Chief Financial Officer, Chris Cage, will engage in a question and answer fireside chat.
A live audio webcast will be accessible on the Leidos Investor Relations website, with a replay available for 30 days thereafter.
Leidos (NYSE: LDOS) has secured a $358 million contract from the U.S. Naval Sea Systems Command to design and construct a medium unmanned undersea vehicle (MUUV). This cost-plus-fixed-fee contract will be executed mainly in Lynnwood, Washington. The MUUV is expected to enhance the Navy's capabilities in submarine-based oceanographic sensing and mine countermeasures. Leidos will collaborate with L3Harris Technologies on this critical project, further solidifying their longstanding partnership with the Navy.
Leidos (NYSE: LDOS) has announced its definitive agreement to acquire Cobham Aviation Services Australia's Special Mission business. This acquisition, which provides crucial airborne border surveillance and search-and-rescue services, is subject to standard closing conditions and regulatory approvals. Leidos aims to enhance its global airborne ISR capabilities, diversifying revenues and expanding service offerings across Australia. Cobham’s Special Mission operates 14 modified aircraft, conducting extensive surveillance and rescue operations, significantly bolstering Leidos' operational capabilities.